These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26100211)

  • 1. MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.
    Choe JY; Yun JY; Na HY; Huh J; Shin SJ; Kim HJ; Paik JH; Kim YA; Nam SJ; Jeon YK; Park G; Kim JE
    Histopathology; 2016 Feb; 68(3):442-9. PubMed ID: 26100211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival.
    Yi S; Zou D; Li C; Zhong S; Chen W; Li Z; Xiong W; Liu W; Liu E; Cui R; Ru K; Zhang P; Xu Y; An G; Lv R; Qi J; Wang J; Cheng T; Qiu L
    Oncotarget; 2015 Dec; 6(39):42362-71. PubMed ID: 26517511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.
    Miao Y; Lin P; Wang W; Jeffrey Medeiros L; Lu X
    Am J Clin Pathol; 2016 Dec; 146(6):747-752. PubMed ID: 28028120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
    Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
    Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
    Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
    Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
    Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
    Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.
    Setoodeh R; Schwartz S; Papenhausen P; Zhang L; Sagatys EM; Moscinski LC; Shao H
    Int J Clin Exp Pathol; 2013; 6(2):155-67. PubMed ID: 23330001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
    Khoury JD; Medeiros LJ; Rassidakis GZ; McDonnell TJ; Abruzzo LV; Lai R
    J Pathol; 2003 Jan; 199(1):90-7. PubMed ID: 12474231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and
    Rodrigues JM; Hollander P; Schmidt L; Gkika E; Razmara M; Kumar D; Geisler C; Grønbæk K; Eskelund CW; Räty R; Kolstad A; Sundström C; Glimelius I; Porwit A; Jerkeman M; Ek S
    Haematologica; 2024 Apr; 109(4):1171-1183. PubMed ID: 37646663
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wang L; Tang G; Medeiros LJ; Xu J; Huang W; Yin CC; Wang M; Jain P; Lin P; Li S
    Haematologica; 2021 May; 106(5):1381-1389. PubMed ID: 32273477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic findings in blastoid mantle cell lymphoma.
    Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
    Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic variations in mantle cell lymphoma.
    Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
    Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
    Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
    Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.
    Seok Y; Kim J; Choi JR; Kim YR; Park SJ; Kim SJ; Song J; Lee KA
    Ann Lab Med; 2012 Jan; 32(1):95-8. PubMed ID: 22259787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic mantle cell lymphoma with a Burkitt translocation.
    Reddy K; Ansari-Lari M; Dipasquale B
    Leuk Lymphoma; 2008 Apr; 49(4):740-50. PubMed ID: 18398742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
    Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
    Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.